Ivermectin tablets are a powerful antiparasitic medication used to treat various parasitic infections in humans and animals. These tablets contain the active ingredient ivermectin, which belongs to a class of drugs known as anthelmintics. Ivermectin tablets have gained significant attention in recent years due to their effectiveness in combating a wide range of parasitic diseases, including strongyloidiasis and onchocerciasis. In this comprehensive guide, we'll explore the key components, mechanisms of action, and unique properties of ivermectin tablets, shedding light on their importance in modern medicine.
1.General Specification(in stock)
(1)Injection
N/A
(2)Tablet
360mg/Tablet,Package:100 tablets/Bottle;80 bottles/Box
(3)API(Pure powder)
PE/Al foil bag/ paper box for Pure powder
HPLC≥99.0%
(4)Pill press machine
https://www.achievechem.com/pill-press
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-2-002
Ivermectin stromectol tablet CAS 70288-86-7
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide Ivermectin tablets, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/oem-odm/tablet/ivermectin-stromectol-tablet.html
Key components and mechanism of action in ivermectin tablets
Ivermectin tablets(https://en.wikipedia.org/wiki/Ivermectin) are formulated with a specific blend of ingredients designed to maximize their antiparasitic effects. The primary active component is ivermectin, a macrocyclic lactone derived from the bacterium Streptomyces avermitilis. This compound works by targeting the nervous systems of parasites, effectively paralyzing and killing them.
The mechanism of action of ivermectin is multifaceted and involves several key processes:
GABA receptor activation
Ivermectin binds to and activates glutamate-gated chloride channels (GluCls) in invertebrate nerve and muscle cells. This activation leads to an influx of chloride ions, resulting in hyperpolarization of the cell membrane and paralysis of the parasite.
Inhibition of neurotransmitter release
Ivermectin interferes with the release of neurotransmitters at synapses, disrupting normal nerve signaling in parasites.
Suppression of protein synthesis
Some studies suggest that ivermectin may also inhibit protein synthesis in parasites, further contributing to their demise.
Modulation of immune response
Ivermectin has been shown to have immunomodulatory effects, potentially enhancing the host's immune response against parasitic infections.
In addition to the active ingredient, ivermectin tablets typically contain several excipients that aid in the drug's stability, absorption, and overall effectiveness. These may include:
Microcrystalline cellulose
A binder and disintegrant that helps maintain tablet integrity and promotes rapid dissolution in the gastrointestinal tract.
Pregelatinized starch
Enhances tablet disintegration and improves flow properties during manufacturing.
Magnesium stearate
A lubricant that prevents tablet ingredients from sticking to manufacturing equipment and improves tablet ejection during production.
Butylated hydroxyanisole
An antioxidant that helps preserve the stability of the active ingredient.
The careful balance of these components ensures that ivermectin tablets deliver the medication effectively to the site of action within the body, maximizing its antiparasitic effects while minimizing potential side effects.
Differences between ivermectin tablets and ivermectin powder formulations
While both ivermectin tablets and powder formulations contain the same active ingredient, there are several key differences in their composition, administration, and applications. Understanding these distinctions is crucial for healthcare providers and patients alike to ensure proper usage and optimal therapeutic outcomes.
Ivermectin tablets are specifically designed for oral administration in humans and some animals. They offer several advantages:
Precise dosing
Tablets come in pre-measured doses, making it easier for patients to take the correct amount of medication.
Improved stability
The tablet formulation provides better protection against environmental factors such as light, heat, and moisture, extending the shelf life of the medication.
Convenience
Tablets are easy to transport, store, and administer, making them ideal for both clinical settings and home use.
Controlled release
Some ivermectin tablets may be formulated with special coatings or matrices to provide controlled release of the active ingredient, potentially improving its efficacy and reducing side effects.
In contrast, ivermectin powder formulations, such as ivomec 10mg, are typically used in veterinary medicine and offer different advantages:
Flexibility in dosing
Powder formulations allow for more precise weight-based dosing, particularly important for large animals or those requiring very small doses.
Versatility in administration
Powders can be mixed with food or water, making it easier to administer to animals that may be difficult to treat with tablets.
Bulk preparation
Powder formulations are often more cost-effective for large-scale use in veterinary settings or agricultural applications.
Topical applications
Some ivermectin powders can be formulated into solutions for topical use, such as pour-on treatments for livestock.
It's important to note that while ivermectina online searches may yield results for both tablet and powder formulations, these products are not interchangeable. Human-grade ivermectin tablets should never be substituted with veterinary powder formulations, as the latter may contain additional ingredients or different concentrations not suitable for human use.
The choice between ivermectin tablets and powder formulations depends on various factors, including the target species, the specific parasitic infection being treated, and the practical considerations of administration. Healthcare providers and veterinarians must carefully consider these factors when prescribing or recommending ivermectin treatments.
How ivermectin tablets target parasitic nervous systems
The efficacy of ivermectin tablets in treating parasitic infections lies in their unique ability to target the nervous systems of invertebrate parasites while having minimal effects on mammalian hosts. This selectivity is due to the drug's specific mechanism of action and the structural differences between parasitic and mammalian nervous systems.
Ivermectin's primary target in parasites is the glutamate-gated chloride channel (GluCl), which is absent in mammals. These channels play a crucial role in the nervous system of invertebrates, regulating various physiological processes. When ivermectin binds to these channels, it causes them to open and remain open, leading to a continuous influx of chloride ions into the nerve cells.
The process by which ivermectin tablets disrupt parasitic nervous systems can be broken down into several key steps:
Binding to GluCl receptors: Ivermectin molecules bind to specific sites on the GluCl receptors, which are primarily located in the motor neurons and pharyngeal muscles of parasites.
Channel activation: Upon binding, ivermectin causes the GluCl channels to open and remain in an open state, allowing a continuous flow of chloride ions into the nerve cells.
Hyperpolarization: The influx of negatively charged chloride ions leads to hyperpolarization of the cell membrane, making it more difficult for the neuron to fire action potentials.
Paralysis: As a result of this hyperpolarization, the parasite's muscles become paralyzed, preventing it from moving, feeding, or reproducing effectively.
Starvation and death: Unable to carry out essential life functions, the parasite eventually starves and dies, allowing the host's immune system to clear the infection.
In addition to its effects on GluCl channels, ivermectin has also been shown to interact with other ligand-gated ion channels in parasites, including GABA receptors. This broad-spectrum activity contributes to its effectiveness against a wide range of parasitic species.
The selectivity of ivermectin for parasitic nervous systems is further enhanced by the blood-brain barrier in mammals, which limits the drug's penetration into the central nervous system. This barrier is less developed or absent in many invertebrate parasites, allowing ivermectin to accumulate more readily in their nervous tissues.
It's worth noting that while ivermectin's primary mechanism of action involves disrupting parasitic nervous systems, recent research has uncovered additional effects that may contribute to its antiparasitic activity:
Inhibition of protein synthesis: Some studies suggest that ivermectin may interfere with protein synthesis in parasites, potentially affecting their growth and reproduction.
Modulation of host immune response: Ivermectin has been shown to have immunomodulatory effects, potentially enhancing the host's ability to clear parasitic infections.
Interference with parasite feeding: In some parasites, ivermectin may disrupt the function of the pharyngeal pump, impairing their ability to feed and absorb nutrients.
Understanding the intricate mechanisms by which ivermectin tablets target parasitic nervous systems has not only led to more effective treatments for existing parasitic infections but has also opened up new avenues for research into novel antiparasitic compounds. As our knowledge of parasite biology and drug interactions continues to grow, we may see the development of even more targeted and efficient antiparasitic medications in the future.
In conclusion, ivermectin tablets represent a remarkable achievement in antiparasitic therapy, offering a potent and selective tool for combating a wide range of parasitic infections. Their unique mechanism of action, targeting the nervous systems of parasites while sparing mammalian hosts, has made them an indispensable weapon in the global fight against parasitic diseases. As research continues to uncover new aspects of ivermectin's activity and potential applications, it's clear that this medication will remain a cornerstone of antiparasitic treatment for years to come.
For pharmaceutical companies, research institutions, and healthcare providers seeking high-quality ivermectin and related compounds, Shaanxi BLOOM TECH Co., Ltd. offers unparalleled expertise and production capabilities. With our state-of-the-art GMP-certified facilities spanning 100,000 square meters and advanced chemical synthesis techniques, we are uniquely positioned to meet the demanding requirements of the pharmaceutical industry. Whether you're looking for bulk quantities of ivermectin for large-scale production or specialized formulations for research purposes, our team is ready to support your needs. To learn more about our ivermectin products and other chemical offerings, please don't hesitate to reach out to us at Sales@bloomtechz.com. Let's work together to advance the field of antiparasitic medicine and improve global health outcomes.
References
Crump, A., & Ōmura, S. (2011). Ivermectin, 'wonder drug' from Japan: the human use perspective. Proceedings of the Japan Academy, Series B, 87(2), 13-28.
Laing, R., Gillan, V., & Devaney, E. (2017). Ivermectin - Old Drug, New Tricks? Trends in Parasitology, 33(6), 463-472.
Canga, A. G., Prieto, A. M. S., Liébana, M. J. D., Martínez, N. F., Vega, M. S., & Vieitez, J. J. G. (2008). The pharmacokinetics and interactions of ivermectin in humans-a mini-review. The AAPS Journal, 10(1), 42-46.
González Canga, A., Sahagún Prieto, A. M., Diez Liébana, M. J., Fernández Martínez, N., Sierra Vega, M., & García Vieitez, J. J. (2008). The pharmacokinetics and interactions of ivermectin in humans-a mini-review. The AAPS Journal, 10(1), 42-46.